
Florida-based Variant, a specialty pharmaceutical firm, innovates improved therapies for Men's Health and more.
Variant Pharmaceuticals, founded in Weston, Florida, is a development-stage specialty pharmaceutical company. The organization leverages proprietary technologies to create and develop formulations aimed at improving therapies for patients, particularly in Men’s Health. With a team boasting over 120 years of combined biopharmaceutical industry experience, Variant focuses on addressing large and growing markets where current treatments are either suboptimal or underdeveloped.
Notable figures affiliated with Variant Pharmaceuticals include seasoned professionals with extensive backgrounds in the biopharmaceutical sector. The company has made significant strides in developing innovative therapies that have the potential to transform patient care. Through its focused approach and expert team, Variant has established itself as a key player in the specialty pharmaceutical space, driving advancements in therapeutic solutions and impacting the broader healthcare market.

Variant Bio
variantbio.com

Manhattan Pharmaceuticals

Vertice Pharma

BiotechInnova
biotechinnova.com

Vanda Pharmaceuticals

Visiox
visioxpharma.com

Solaris Pharma
solaris-pharma.com

Variantyx
variantyx.com

Auxilius Pharma
auxiliuspharma.com

Fervent Pharmaceuticals
ferventpharma.com

Marius Pharmaceuticals
mariuspharma.com
Vertex Pharmaceuticals
vrtx.com

Response Pharmaceuticals

PleoPharma
pleopharma.com

Aria Pharmaceuticals
Companies similar to Variant Pharmaceuticals include Variant Bio, Manhattan Pharmaceuticals, Vertice Pharma and BiotechInnova.
Variant Pharmaceuticals was founded in 2014.
Variant Pharmaceuticals' headquarters is located in Weston, FL, US.
Variant Pharmaceuticals' most recent funding round was for $10M (USD) in December 2018.
As of Dec 3, 2018, Variant Pharmaceuticals has raised a total of $14.4M (USD).
Variant Pharmaceuticals has 7 employees as of Feb 4, 2024.